These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2658391)

  • 21. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A study on reflux esophagitis--clinical nonsense].
    Jaup BH
    Lakartidningen; 1992 Sep; 89(40):3270. PubMed ID: 1405942
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prognostic factors influencing healing of reflux esophagitis. A controlled trial of omeprazole versus ranitidine. Study group Omega].
    Barbier JP; Haccoun P; Bergmann JF; Arnould B; Hamelin B
    Ann Gastroenterol Hepatol (Paris); 1993; 29(4):213-8. PubMed ID: 8239492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Omeprazole].
    Isal JP
    Gastroenterol Clin Biol; 1987 Nov; 11(11):768-80. PubMed ID: 3322924
    [No Abstract]   [Full Text] [Related]  

  • 26. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
    Festen HP; Schenk E; Tan G; Snel P; Nelis F
    Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Reflux esophagitis; is the preventive eradication of Helicobacter pylori needed in patients on omeprazole?].
    Kuipers EJ; Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Ned Tijdschr Geneeskd; 1998 Apr; 142(16):883-5. PubMed ID: 9623181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Proton pump inhibitors in the treatment of reflux esophagitis].
    Bigard MA
    Rev Prat; 1994 Oct; 44(15):1992-6. PubMed ID: 7984887
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of gastroesophageal reflux: the role of proton pump inhibitors.
    Schulman MI; Orlando RC
    Adv Intern Med; 1995; 40():273-302. PubMed ID: 7747649
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.
    Noordzij JP; Khidr A; Evans BA; Desper E; Mittal RK; Reibel JF; Levine PA
    Laryngoscope; 2001 Dec; 111(12):2147-51. PubMed ID: 11802014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.
    Castell DO; Richter JE; Robinson M; Sontag SJ; Haber MM
    Am J Gastroenterol; 1996 Sep; 91(9):1749-57. PubMed ID: 8792693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic markers in reflux esophagitis better than wrapped up recommendations].
    Lindberg G; Jönsson B
    Lakartidningen; 1992 Dec; 89(49):4243-4. PubMed ID: 1461046
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical correlation on a subject with esophagitis].
    Blum AL
    Rev Med Suisse Romande; 1993 Aug; 113(8):662. PubMed ID: 8372315
    [No Abstract]   [Full Text] [Related]  

  • 34. [Maintenance treatment in reflux esophagitis: the role of omeprazole].
    Díaz de Rojas F; Castelló M; Mariño M
    Rev Esp Enferm Dig; 1992 Mar; 81(3):215-8. PubMed ID: 1567727
    [No Abstract]   [Full Text] [Related]  

  • 35. Maintenance therapies for reflux esophagitis.
    Yarze JC
    N Engl J Med; 1996 Feb; 334(9):600-1. PubMed ID: 8569839
    [No Abstract]   [Full Text] [Related]  

  • 36. [Reduced suppression of gastric acid by ranitidine in severe reflux esophagitis. A pilot study].
    Koop H; Klein M; Bauer A; Arnold R
    Z Gastroenterol; 1988 Jul; 26(7):345-50. PubMed ID: 3223004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Observations regarding internet-based applications in gastroenterology specialty practices--aspects of quality control].
    Ose C; Hirche H; Jöckel KH; Küppers B; Warth L; Rammler B
    Stud Health Technol Inform; 2000; 77():348-52. PubMed ID: 11187572
    [No Abstract]   [Full Text] [Related]  

  • 38. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omeprazole in short term treatment of reflux oesophagitis.
    Jafri W; Abbas Z; Hamid S; Abid S; Shah H; Khan H
    J Pak Med Assoc; 1992 Dec; 42(12):290-2. PubMed ID: 1299735
    [No Abstract]   [Full Text] [Related]  

  • 40. Omeprazole decreased formation of monoethylglycinexylidide in a patient with chronic active hepatitis.
    Campo N; Alvarez S; Borzone S; Caglieris S; Zentilin P; Testa R
    Am J Gastroenterol; 1994 Aug; 89(8):1271-2. PubMed ID: 8053457
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.